PFM Health Sciences’s Veeva Systems VEEV Stock Holding History

PFM Health Sciences’s Portfolio VEEV Stock Details VEEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,489	Closed	-$7.25M	–	102
2025 Q4	$7.25M	Sell	32,489 -9,014	-22%	-$2.39M	0.72%	42
2025 Q3	$12.4M	Buy	+41,503	New	+$11.7M	0.95%	34
2025 Q1	–	Sell	-55,383	Closed	-$11.6M	–	93
2024 Q4	$11.6M	Buy	55,383 +36,124	+188%	+$7.94M	0.72%	39
2024 Q3	$4.04M	Buy	+19,259	New	+$3.81M	0.23%	55
2024 Q2	–	Sell	-118,905	Closed	-$27.5M	–	92
2024 Q1	$27.5M	Hold	118,905	–	–	1.3%	30
2023 Q4	$22.9M	Hold	118,905	–	–	1.37%	26
2023 Q3	$24.2M	Buy	118,905 +81,484	+218%	+$16.4M	1.14%	38
2023 Q2	$7.4M	Buy	+37,421	New	+$6.82M	0.29%	63
2022 Q4	–	Sell	-202,387	Closed	-$33.4M	–	98
2022 Q3	$33.4M	Hold	202,387	–	–	1.21%	38
2022 Q2	$40.1M	Buy	+202,387	New	+$37.2M	1.53%	24

Other funds holding VEEV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's VEEV Position: Q1 2026 in Review

PFM Health Sciences sold out of Veeva Systems (VEEV) in Q1 2026, closing a stake of 32,489 shares — an estimated $7.25M sold.

PFM Health Sciences first reported a position in VEEV in Q2 2022 and held it in 10 quarters. The position peaked at $40.1M in Q2 2022. 1,016 funds tracked by Wall St. Rank hold VEEV as of Q1 2026.

PFM Health Sciences reported no remaining Veeva Systems position as of Q1 2026 after selling out during the quarter.
PFM Health Sciences sold 32,489 Veeva Systems shares in Q1 2026, an estimated $7.25M.
PFM Health Sciences first reported a position in Veeva Systems in Q2 2022 and held it in 10 quarters.
PFM Health Sciences's Veeva Systems position peaked at $40.1M in Q2 2022.
1,016 funds tracked by Wall St. Rank held Veeva Systems as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.